Huawei plans for more AI pharma tie-ups, says healthcare president

SHANGHAI — Chinese technology conglomerate Huawei plans to expand its AI co-operation with local pharmaceutical firms into drug development and clinical practice, a senior executive said.The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are investing in modelling tools and automated laboratories to shorten development timelines and improve efficiency."As we...